| Hana K Ryan, AGPCNP-BC | |
|
11695 Ne 4th St, Bellevue, WA 98004-5268 | |
| (425) 637-1855 | |
| (425) 344-7970 |
| Full Name | Hana K Ryan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 11695 Ne 4th St, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033684428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | 209018364 (Illinois) | Secondary |
| 363L00000X | Nurse Practitioner | AP60997761 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Mason Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Mason Medical Center | 9830002617 | 825 |
News Archive
The anticonvulsant medication gabapentin—already a useful part of strategies to control pain after surgery—also effectively reduces the common complication of postoperative nausea and vomiting (PONV), reports a study in Anesthesia & Analgesia.
A pediatric urologist at UT Southwestern Medical Center who pioneered a surgical technique for repairing a common birth defect in boys reports the procedure is singularly effective in correcting the problem with few complications.
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Also in the news, the Centers for Medicare & Medicaid Services announced nearly $50 million in grants to state agencies to help seniors better understand Medicare.
› Verified 8 days ago
| Entity Name | Virginia Mason Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801851258 PECOS PAC ID: 9830002617 Enrollment ID: O20031107000383 |
News Archive
The anticonvulsant medication gabapentin—already a useful part of strategies to control pain after surgery—also effectively reduces the common complication of postoperative nausea and vomiting (PONV), reports a study in Anesthesia & Analgesia.
A pediatric urologist at UT Southwestern Medical Center who pioneered a surgical technique for repairing a common birth defect in boys reports the procedure is singularly effective in correcting the problem with few complications.
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Also in the news, the Centers for Medicare & Medicaid Services announced nearly $50 million in grants to state agencies to help seniors better understand Medicare.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hana K Ryan, AGPCNP-BC 1100 9th Ave, M4-pfs, Seattle, WA 98101-2756 Ph: (206) 515-5811 | Hana K Ryan, AGPCNP-BC 11695 Ne 4th St, Bellevue, WA 98004-5268 Ph: (425) 637-1855 |
News Archive
The anticonvulsant medication gabapentin—already a useful part of strategies to control pain after surgery—also effectively reduces the common complication of postoperative nausea and vomiting (PONV), reports a study in Anesthesia & Analgesia.
A pediatric urologist at UT Southwestern Medical Center who pioneered a surgical technique for repairing a common birth defect in boys reports the procedure is singularly effective in correcting the problem with few complications.
Osiris Therapeutics, Inc. today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Also in the news, the Centers for Medicare & Medicaid Services announced nearly $50 million in grants to state agencies to help seniors better understand Medicare.
› Verified 8 days ago
Ms. Jessica Swenson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1231 116th Ave Ne, Suite 950, Bellevue, WA 98004 Phone: 425-454-3366 Fax: 425-460-5954 | |
Mrs. Kara Harrington Brennan, MSN, ARNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 11522 Ne 20th St, Bellevue, WA 98004 Phone: 425-462-2531 Fax: 425-454-6176 | |
Dr. Ambera Dedic, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1231 116th Ave Ne Ste 400, Bellevue, WA 98004 Phone: 425-289-3199 | |
Keenan Smith, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2105 112th Ave Ne Ste 201, Bellevue, WA 98004 Phone: 425-968-5948 | |
Leslie Elaine Smith, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1600 116th Ave Ne, Suite #102, Bellevue, WA 98004 Phone: 425-454-5311 Fax: 425-454-8188 | |
Thomas Chan, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15585 Ne 24th St, Bellevue, WA 98007 Phone: 888-227-3312 |